BlackRock’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$132K Sell
336,789
-70,092
-17% -$27.4K ﹤0.01% 4702
2025
Q1
$126K Sell
406,881
-1,266
-0.3% -$392 ﹤0.01% 4664
2024
Q4
$171K Sell
408,147
-417
-0.1% -$175 ﹤0.01% 4599
2024
Q3
$401K Sell
408,564
-301,476
-42% -$296K ﹤0.01% 4328
2024
Q2
$1.08M Sell
710,040
-1,026,328
-59% -$1.56M ﹤0.01% 4108
2024
Q1
$3.94M Sell
1,736,368
-131,061
-7% -$298K ﹤0.01% 3718
2023
Q4
$5.47M Buy
1,867,429
+113,550
+6% +$333K ﹤0.01% 3582
2023
Q3
$7.42M Sell
1,753,879
-29,359
-2% -$124K ﹤0.01% 3440
2023
Q2
$15.6M Buy
1,783,238
+1,651,714
+1,256% +$14.5M ﹤0.01% 3117
2023
Q1
$408K Sell
131,524
-149
-0.1% -$462 ﹤0.01% 4497
2022
Q4
$1.61M Sell
131,673
-79,097
-38% -$964K ﹤0.01% 4149
2022
Q3
$1.79M Buy
210,770
+6,337
+3% +$53.9K ﹤0.01% 4156
2022
Q2
$3.31M Sell
204,433
-464,962
-69% -$7.54M ﹤0.01% 3923
2022
Q1
$8.07M Sell
669,395
-5,035
-0.7% -$60.7K ﹤0.01% 3622
2021
Q4
$11M Buy
674,430
+127,664
+23% +$2.08M ﹤0.01% 3556
2021
Q3
$8.67M Buy
546,766
+13,875
+3% +$220K ﹤0.01% 3679
2021
Q2
$49.2M Buy
532,891
+386,769
+265% +$35.7M ﹤0.01% 2677
2021
Q1
$7.6M Buy
146,122
+50,879
+53% +$2.65M ﹤0.01% 3671
2020
Q4
$2.57M Buy
95,243
+457
+0.5% +$12.3K ﹤0.01% 3884
2020
Q3
$2.65M Hold
94,786
﹤0.01% 3726
2020
Q2
$1.37M Sell
94,786
-12,375
-12% -$178K ﹤0.01% 3870
2020
Q1
$1.2M Sell
107,161
-183
-0.2% -$2.05K ﹤0.01% 3745
2019
Q4
$2.23M Buy
107,344
+31,106
+41% +$647K ﹤0.01% 3696
2019
Q3
$1.78M Buy
76,238
+3,556
+5% +$83.2K ﹤0.01% 3744
2019
Q2
$2.18M Buy
72,682
+2,680
+4% +$80.4K ﹤0.01% 3699
2019
Q1
$1.44M Buy
70,002
+99
+0.1% +$2.04K ﹤0.01% 3761
2018
Q4
$1.99M Sell
69,903
-513
-0.7% -$14.6K ﹤0.01% 3636
2018
Q3
$3.03M Buy
70,416
+3,471
+5% +$149K ﹤0.01% 3591
2018
Q2
$2.61M Buy
66,945
+44,693
+201% +$1.74M ﹤0.01% 3603
2018
Q1
$467K Sell
22,252
-21
-0.1% -$441 ﹤0.01% 4010
2017
Q4
$361K Buy
22,273
+88
+0.4% +$1.43K ﹤0.01% 4044
2017
Q3
$701K Sell
22,185
-85
-0.4% -$2.69K ﹤0.01% 3928
2017
Q2
$699K Buy
22,270
+21
+0.1% +$659 ﹤0.01% 3884
2017
Q1
$979K Buy
+22,249
New +$979K ﹤0.01% 3774
2014
Q2
Sell
-935
Closed -$304K 3116
2014
Q1
$304K Buy
+935
New +$304K ﹤0.01% 1420